Anti-mullerian hormone:: clinical relevance in assisted reproductive therapy

被引：13
作者：
Freour, T. [1 ]
Mirallie, S.
Colombel, A.
Bach-Ngohou, K.
Masson, D.
Barriere, P.
机构：
[1] CHU Nantes, Serv Med Reprod, F-44035 Nantes 01, France
[2] CHU Nantes, Lab Biochim Specialisee, F-44035 Nantes, France
来源：
ANNALES D ENDOCRINOLOGIE | 2006年 / 67卷 / 06期
关键词：
anti-Mullerian hormone; ovarian reserve;
D O I：
10.1016/S0003-4266(06)73008-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Anti-Mullerian Hormone (AMH) is a member of the transforming Growth Factor-P (TGF-beta) family synthesized exclusively by the gonads of both sexes. Over the last four years, numerous studies have examined the clinical usefulness of serum AMH levels as a predictor of ovarian response and pregnancy in assisted reproductive technology cycles. Assessment of ovarian reserve in women undergoing assisted reproduction is useful in optimising the treatment protocol. Availability of a reliable measure of ovarian reserve is essential. Currently, serum AMH level seems to be more strongly related to the ovarian reserve and to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B or estradiol, which are more commonly used markers. Our study involving 69 women undergoing a cycle of in vitro fertilisation (IVF) or intracytoplamic sperm injection (ICSI) treatment, confirmed these results. We have shown in this study that AMH is significantly correlated with the number of eggs collected and is of great interest as a negative predictive value for the success of assisted reproductive technology (ART). Further studies are needed to determine AMH cut-off values.
引用
收藏
页码：567 / 574
页数：8
相关论文
共 49 条
[1]   Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound [J].
Bath, LE ;
Wallace, WHB ;
Shaw, MP ;
Fitzpatrick, C ;
Anderson, RA .
HUMAN REPRODUCTION, 2003, 18 (11) :2368-2374
[2]   Mutations of the anti-Mullerian hormone gene in patients with persistent Mullerian duct syndrome: Biosynthesis, secretion, and processing of the abnormal proteins and analysis using a three-dimensional model [J].
Belville, C ;
Van Vlijmen, H ;
Ehrenfels, C ;
Pepinsky, B ;
Rezaie, AR ;
Picard, JY ;
Josso, N ;
di Clemente, N ;
Cate, RL .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (03) :708-721
[3]   Mullerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B [J].
Chu, MC ;
Carmina, E ;
Wang, J ;
Lobo, RA .
FERTILITY AND STERILITY, 2005, 84 (06) :1685-1688
[4]   Relationship between serum mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women [J].
Cook, CL ;
Siow, Y ;
Brenner, AG ;
Fallat, ME .
FERTILITY AND STERILITY, 2002, 77 (01) :141-146
[5]   Serum mullerian-inhibiting substance levels during normal menstrual cycles [J].
Cook, CL ;
Siow, Y ;
Taylor, S ;
Fallat, ME .
FERTILITY AND STERILITY, 2000, 73 (04) :859-861
[6]   Antimullerian hormone serum levels: a putative marker for ovarian aging [J].
de Vet, A ;
Laven, JSE ;
de Jong, FH ;
Themmen, APN ;
Fauser, BCJM .
FERTILITY AND STERILITY, 2002, 77 (02) :357-362
[7]  
Deffieux X, 2003, Gynecol Obstet Fertil, V31, P900, DOI 10.1016/j.gyobfe.2003.08.012
[8]   Components of the anti-Mullerian hormone signaling pathway in gonads [J].
di Clemente, N ;
Josso, N ;
Gouédard, L ;
Belville, C .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2003, 211 (1-2) :9-14
[9]   Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary [J].
Durlinger, ALL ;
Kramer, P ;
Karels, B ;
de Jong, FH ;
Uilenbroek, JTJ ;
Grootegoed, JA ;
Themmen, APN .
ENDOCRINOLOGY, 1999, 140 (12) :5789-5796
[10]   Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary [J].
Durlinger, ALL ;
Gruijters, MJG ;
Kramer, P ;
Karels, B ;
Kumar, TR ;
Matzuk, MM ;
Rose, UM ;
de Jong, FH ;
Uilenbroek, JTJ ;
Grootegoed, JA ;
Themmen, APN .
ENDOCRINOLOGY, 2001, 142 (11) :4891-4899
12345